We postulate that while the expression of CD95L on memory CAR-T cells will accelerate the differentiation/exhaustion of TSCM cells and thus reduce the persistence of CAR-T cells, the release of sCD95L will instead enhance the anti-tumor response. This evidence concerns the gene FASLG and neoplasm.